The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications
about
sameAs
Bone morphogenetic protein (BMP) for fracture healing in adultsAn Activin A/BMP2 Chimera, AB204, Displays Bone-Healing Properties Superior to Those of BMP2Ecto-protein kinases and phosphatases: an emerging field for translational medicine.Immobilization of murine anti-BMP-2 monoclonal antibody on various biomaterials for bone tissue engineering.Fold change and p-value cutoffs significantly alter microarray interpretations.The effects of secretion factors from umbilical cord derived mesenchymal stem cells on osteogenic differentiation of mesenchymal stem cells.Effects of the orientation of anti-BMP2 monoclonal antibody immobilized on scaffold in antibody-mediated osseous regenerationEnhancing osteoconduction of PLLA-based nanocomposite scaffolds for bone regeneration using different biomimetic signals to MSCs.NELL-1 in the treatment of osteoporotic bone loss.Novel Wnt Regulator NEL-Like Molecule-1 Antagonizes Adipogenesis and Augments Osteogenesis Induced by Bone Morphogenetic Protein 2NELL-1 injection maintains long-bone quantity and quality in an ovariectomy-induced osteoporotic senile rat model.Integration of a novel injectable nano calcium sulfate/alginate scaffold and BMP2 gene-modified mesenchymal stem cells for bone regeneration.Nanoparticulate mineralized collagen scaffolds induce in vivo bone regeneration independent of progenitor cell loading or exogenous growth factor stimulation.Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering.Functionalization of scaffolds with chimeric anti-BMP-2 monoclonal antibodies for osseous regeneration.Adenovirus-mediated siRNA targeting TNF-α and overexpression of bone morphogenetic protein-2 promotes early osteoblast differentiation on a cell model of Ti particle-induced inflammatory response in vitroCollagen Sponge Functionalized with Chimeric Anti-BMP-2 Monoclonal Antibody Mediates Repair of Critical-Size Mandibular Continuity Defects in a Nonhuman Primate Model.Short Anabolic Peptides for Bone Growth.Antagonism of the Met5-enkephalin-opioid growth factor receptor-signaling axis promotes MSC to differentiate into osteoblasts.Osteogenic differentiation induced by bone morphogenetic proteins can be suppressed by platelet-released supernatant in vitro.Regeneration of bone using nanoplex delivery of FGF-2 and BMP-2 genes in diaphyseal long bone radial defects in a diabetic rabbit model.Biomechanical analysis of engineered bone with anti-BMP2 antibody immobilized on different scaffolds.Chemically modified RNA activated matrices enhance bone regeneration.Differential effects of amnion and chorion membrane extracts on osteoblast-like cells due to the different growth factor composition of the extracts.Toxicity of Flow Line, Durafill VS, and Dycal to dental pulp cells: effects of growth factorsHypoxic adipocytes pattern early heterotopic bone formation.Construction and characterization of a recombinant human adenovirus vector expressing bone morphogenetic protein 2.Pin1 plays a critical role as a molecular switch in canonical BMP signaling.Osteogenic Programming of Human Mesenchymal Stem Cells with Highly Efficient Intracellular Delivery of RUNX2.Effect of Recombinant Human Bone Morphogenetic Protein-2 and Adipose Tissue-Derived Stem Cell on New Bone Formation in High-Speed Distraction Osteogenesis.Controlled release of BMP-2 using a heparin-conjugated carrier system reduces in vivo adipose tissue formation.Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a histological and histomorphometric study in the Goettingen miniature pig.Antibody-Mediated Osseous Regeneration for Bone Tissue Engineering in Canine Segmental Defects.
P2860
Q24234838-08F0F5CE-E91B-4436-AACE-29EFAA074AD0Q27682737-64B119F6-4FB5-4EE8-9470-56DE0F16E622Q27682737-B0BF6736-FB84-4A79-850D-B16F6E42E5E1Q33807709-02BE81FE-444E-4065-A474-CF2CAC86B591Q33807709-6B1EF377-5453-4ED6-9A43-194C8ED0DA95Q34043034-0A60442D-A511-4D08-BAA1-323B05369642Q34043034-84BD6E1A-5BD5-431F-9112-89D5AFC3D681Q34247749-5A3E593E-C4A2-4A3A-ADE7-88DB448C1379Q34247749-A0261199-20B5-4139-A62A-B894504811C3Q35584038-57C6F526-70D9-49A3-815C-2E6EAC74CFA1Q35584038-6B4E306E-5442-43A0-BE0E-286A527FE2B2Q35694061-2574F73F-F672-4067-AA43-55AA07908016Q35694061-82F8C71F-6937-4585-A099-3790CFDE7D63Q35795933-3051B95C-06FC-4499-9608-14B5DCEC89BEQ35795933-E7507CC4-2801-407A-A7C9-59A729FBDD2DQ36018565-746747B9-5233-4DDF-BF67-A30B483A8F85Q36018565-C22AC687-BE88-4AF5-87DB-E4C851F82A39Q36509203-02D475F6-2100-49F7-AB78-2C8BFBB03A9DQ36509203-3BB32811-E30C-4957-8989-C079FB52BED1Q36525894-470A4D38-1E72-48A1-A369-EC92430BB74CQ36525894-D08DB075-2A78-48BF-A64C-03B79DCC57EEQ36525932-17C0A7AE-8845-4C6D-B376-B5DAFEC4674AQ36525932-BA4D44E8-D891-4BC3-9DEA-077370067A62Q36912171-5834CD91-0649-42FD-A875-0853E13F2EEEQ36912171-A28802E4-9DC6-4A55-8DE1-BCE44ACB7506Q37026137-340C6995-2DA9-4425-B9B9-220B1F5073F8Q37026137-BC252CC2-29AB-4F59-BF00-E89C54792FDBQ37338417-E46B4F68-E8CA-4064-8BB3-2FF3466CD4D9Q37338417-EE515A16-3C14-42CD-9BAB-FCBE34501AC3Q37371220-C54CD413-3054-4C4B-B41A-396DB92FA694Q37371220-DD970750-7B46-4C4A-89CD-7B234F5E0891Q37733510-509D090F-1560-4152-8C31-1A2879CD0A50Q37733510-910D3854-5813-4B68-8BD6-3B78B78B1FB3Q38864194-01B62EBA-2966-47B9-A0E2-FF13E50E4F5DQ40189040-C6CD168F-B4D1-4AF1-8268-AD1CE4824146Q40296735-55E98493-7D7F-490E-A87F-63F3C7EEF4BBQ40388484-05892454-6140-4301-9834-7F95E481F139Q40388484-2B9407DF-8CCA-4529-B2AF-103E4BF81EDDQ40648322-1E27CEB8-B902-4601-B496-5467CF015589Q40648322-F5C89223-1D41-4A47-B130-7BC5B5495F96
P2860
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The use of recombinant human b ...... 2) in orthopaedic applications
@ast
The use of recombinant human b ...... 2) in orthopaedic applications
@en
The use of recombinant human b ...... 2) in orthopaedic applications
@nl
type
label
The use of recombinant human b ...... 2) in orthopaedic applications
@ast
The use of recombinant human b ...... 2) in orthopaedic applications
@en
The use of recombinant human b ...... 2) in orthopaedic applications
@nl
prefLabel
The use of recombinant human b ...... 2) in orthopaedic applications
@ast
The use of recombinant human b ...... 2) in orthopaedic applications
@en
The use of recombinant human b ...... 2) in orthopaedic applications
@nl
P2860
P1476
The use of recombinant human b ...... 2) in orthopaedic applications
@en
P2093
Joseph M Lane
Safdar N Khan
P2860
P356
10.1517/14712598.4.5.741
10.1517/EOBT.4.5.741.31055
P407
P577
2004-05-01T00:00:00Z